Method for the treatment of thromboembolism
AssigneeBoston Scientific Scimed, Inc.
InventorLynn Gourley Allen
Life of this patent
Estimating the term…
Abstract
A method for the treatment of thromboembolism comprising administering a thrombolytic agent directly to the thromboembolism in the presence of ultrasound. The total dose of thrombolytic agent administered is between 1 and 12 mg and the time over which the total dose is delivered is less than 15 hours.
Claims20
A thrombolytic agent for use in a treatment of a thromboembolism, wherein the treatment comprises administering the thrombolytic agent directly to the thromboembolism in the presence of ultrasound, wherein a total dose of the thrombolytic agent is between 0.1 and 12 mg and is administered as one or more small bolus doses of between 0.1 and 0.9 mg, and the time over which the total dose of the thrombolytic agent is delivered is 6 hours or less.
A thrombolytic agent for use in a treatment of a thromboembolism, wherein the treatment comprises administering the thrombolytic agent directly to the thromboembolism in the presence of ultrasound, wherein a total dose of the thrombolytic agent administered is between 0.1 and 0.9 mg and the time over which the total dose of the thrombolytic agent is delivered is 1 hour or less.
A method for treating a thromboembolism, the method comprising:
- administering a thrombolytic agent to a patient with a thromboembolism;
- wherein administering the thrombolytic agent to the patient includes administering the thrombolytic agent directly to the thromboembolism in the presence of ultrasound;
- wherein a total dose of the thrombolytic agent is between 0.1 and 12 mg;
- wherein the total dose is administered as one or more bolus doses of between 0.1 and 0.9 mg;
- and
- wherein the time over which the total dose is delivered is 6 hours or less.
Dependencies are inferred from the claim text.